Trupanion, Inc. (NASDAQ:TRUP – Get Free Report) CEO Margaret Tooth sold 491 shares of Trupanion stock in a transaction dated Tuesday, August 25th. The shares were sold at an average price of $31.84, for a total transaction of $15,633.44. Following the sale, the chief executive officer owned 186,952 shares in the company, valued at approximately $5,952,551.68. This represents a 0.26% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.
Margaret Tooth also recently made the following trade(s):
- On Tuesday, August 11th, Margaret Tooth sold 978 shares of Trupanion stock. The shares were sold at an average price of $29.05, for a total transaction of $28,410.90.
Trupanion Stock Down 5.2%
TRUP stock opened at $30.19 on Thursday. The firm’s 50-day moving average is $26.76 and its two-hundred day moving average is $26.00. The company has a market capitalization of $1.32 billion, a price-to-earnings ratio of 56.96, a price-to-earnings-growth ratio of 2.15 and a beta of 1.39. Trupanion, Inc. has a 52 week low of $21.16 and a 52 week high of $46.98. The company has a current ratio of 1.77, a quick ratio of 1.77 and a debt-to-equity ratio of 0.24.
Analyst Ratings Changes
A number of brokerages have weighed in on TRUP. Atlantic Securities set a $42.00 price target on shares of Trupanion in a report on Wednesday, July 15th. Weiss Ratings upgraded shares of Trupanion from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, August 12th. Zacks Research cut shares of Trupanion from a “strong-buy” rating to a “hold” rating in a report on Monday. Piper Sandler lowered shares of Trupanion from an “overweight” rating to a “neutral” rating and decreased their price target for the stock from $45.00 to $32.00 in a research report on Wednesday. Finally, Stifel Nicolaus upped their price target on Trupanion from $28.00 to $29.00 and gave the company a “hold” rating in a report on Thursday, August 20th. One equities research analyst has rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, Trupanion has a consensus rating of “Hold” and an average target price of $39.20.
View Our Latest Stock Analysis on TRUP
Institutional Trading of Trupanion
Several large investors have recently added to or reduced their stakes in the company. BlackRock Inc. acquired a new stake in Trupanion during the 2nd quarter worth about $134,774,000. Polar Capital Holdings Plc increased its stake in shares of Trupanion by 13.5% during the 4th quarter. Polar Capital Holdings Plc now owns 1,475,000 shares of the financial services provider’s stock worth $55,121,000 after purchasing an additional 175,000 shares during the last quarter. State Street Corp raised its holdings in Trupanion by 2.2% during the fourth quarter. State Street Corp now owns 1,290,987 shares of the financial services provider’s stock valued at $48,244,000 after buying an additional 27,385 shares in the last quarter. Marshall Wace LLP raised its stake in shares of Trupanion by 4.5% in the 4th quarter. Marshall Wace LLP now owns 1,267,262 shares of the financial services provider’s stock valued at $47,358,000 after acquiring an additional 55,111 shares in the last quarter. Finally, California State Teachers Retirement System raised its position in shares of Trupanion by 2,314.7% in the second quarter. California State Teachers Retirement System now owns 1,166,023 shares of the financial services provider’s stock valued at $28,882,000 after purchasing an additional 1,117,735 shares during the period.
About Trupanion
Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.
Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.
See Also
- Five stocks we like better than Trupanion
- J.M. Smucker’s Rally Nears a Key Test: Is a Full Recovery Ahead?
- Williams-Sonoma’s Quarter Gave Bulls More Than Just a Beat-and-Raise
- Alcoa’s Gallium Project Opens a New Door Beyond Aluminum
- Oura’s $16 Billion IPO Could Put a New Price on Wearable Tech
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.
